PRINCIPAL FINANCIAL GROUP INC - HAEMONETICS CORP ownership

HAEMONETICS CORP's ticker is HAE and the CUSIP is 405024100. A total of 289 filers reported holding HAEMONETICS CORP in Q4 2020. The put-call ratio across all filers is 1.18 and the average weighting 0.1%.

Quarter-by-quarter ownership
PRINCIPAL FINANCIAL GROUP INC ownership history of HAEMONETICS CORP
ValueSharesWeighting
Q2 2024$15,941,410
-11.8%
192,692
-9.0%
0.01%
-18.2%
Q1 2024$18,066,632
+3.6%
211,677
+3.8%
0.01%0.0%
Q4 2023$17,440,961
-2.3%
203,964
+2.3%
0.01%
-15.4%
Q3 2023$17,858,669
+5.7%
199,360
+0.4%
0.01%
+8.3%
Q2 2023$16,901,653
-1.5%
198,516
-4.3%
0.01%0.0%
Q1 2023$17,165,991
+4.5%
207,444
-0.7%
0.01%0.0%
Q4 2022$16,422,514
+4.0%
208,805
-2.1%
0.01%
-7.7%
Q3 2022$15,796,000
+2.3%
213,371
-9.9%
0.01%
+18.2%
Q2 2022$15,441,000
+34.0%
236,898
+29.9%
0.01%
+57.1%
Q1 2022$11,526,000
+18.4%
182,315
-0.7%
0.01%
+16.7%
Q4 2021$9,738,000
-23.7%
183,597
+1.6%
0.01%
-25.0%
Q3 2021$12,762,000
+6.1%
180,790
+0.2%
0.01%0.0%
Q2 2021$12,027,000
-71.5%
180,471
-52.6%
0.01%
-73.3%
Q1 2021$42,245,000
+132.1%
380,548
+148.3%
0.03%
+130.8%
Q4 2020$18,200,000
+35.6%
153,263
-0.3%
0.01%
+18.2%
Q3 2020$13,418,000
-5.6%
153,784
-3.1%
0.01%
-15.4%
Q2 2020$14,220,000
-9.6%
158,777
+0.6%
0.01%
-23.5%
Q1 2020$15,731,000
-38.7%
157,850
-29.3%
0.02%
-19.0%
Q4 2019$25,657,000
-9.5%
223,293
-0.7%
0.02%
-16.0%
Q3 2019$28,364,000
+2.8%
224,857
-1.9%
0.02%0.0%
Q2 2019$27,594,000
+33.1%
229,304
-3.2%
0.02%
+31.6%
Q1 2019$20,729,000
-12.9%
236,962
-0.4%
0.02%
-24.0%
Q4 2018$23,805,000
-20.2%
237,931
-8.6%
0.02%
-3.8%
Q3 2018$29,822,000
+29.8%
260,278
+1.6%
0.03%
+23.8%
Q2 2018$22,972,000
-29.7%
256,154
-42.6%
0.02%
-32.3%
Q1 2018$32,662,000
+30.7%
446,448
+3.7%
0.03%
+34.8%
Q4 2017$24,997,000
+29.3%
430,375
-0.1%
0.02%
+21.1%
Q3 2017$19,340,000
+12.7%
431,013
-0.8%
0.02%
+11.8%
Q2 2017$17,154,000
+4.2%
434,390
+7.1%
0.02%
-15.0%
Q1 2017$16,455,000
+4.9%
405,578
+3.9%
0.02%0.0%
Q4 2016$15,687,000
+14.1%
390,209
+2.7%
0.02%
+11.1%
Q3 2016$13,754,000
+32.0%
379,833
+5.7%
0.02%
+20.0%
Q2 2016$10,422,000
-16.9%
359,520
+0.3%
0.02%
-16.7%
Q1 2016$12,542,000
+13.1%
358,559
+4.2%
0.02%
+12.5%
Q4 2015$11,094,000
+4.9%
344,105
+5.1%
0.02%
-5.9%
Q3 2015$10,580,000
-21.0%
327,337
+1.1%
0.02%
-15.0%
Q2 2015$13,388,000
-9.4%
323,710
-1.6%
0.02%
-9.1%
Q1 2015$14,770,000
+23.4%
328,814
+2.8%
0.02%
+15.8%
Q4 2014$11,970,000
+6.8%
319,879
-0.4%
0.02%0.0%
Q3 2014$11,212,000
-3.3%
321,070
-2.3%
0.02%0.0%
Q2 2014$11,590,000
+7.6%
328,533
-0.6%
0.02%0.0%
Q1 2014$10,771,000
-19.3%
330,479
+4.3%
0.02%
-24.0%
Q4 2013$13,346,000
+12.6%
316,783
+6.6%
0.02%
+4.2%
Q3 2013$11,856,000
-0.2%
297,283
+3.4%
0.02%
-7.7%
Q2 2013$11,884,000287,3960.03%
Other shareholders
HAEMONETICS CORP shareholders Q4 2020
NameSharesValueWeighting ↓
HealthCor Management, L.P. 538,962$61,927,0002.21%
Parkman Healthcare Partners LLC 60,250$6,923,0002.00%
Bridge City Capital, LLC 40,541$4,658,0001.92%
Millrace Asset Group, Inc. 14,665$1,685,0001.83%
Nitorum Capital, L.P. 280,586$32,239,0001.80%
COOKSON PEIRCE & CO INC 136,101$15,638,0001.38%
EMERALD ADVISERS, LLC 248,520$28,555,0001.21%
SUMMIT PARTNERS PUBLIC ASSET MANAGEMENT, LLC 110,161$12,657,0001.20%
EMERALD MUTUAL FUND ADVISERS TRUST 239,240$27,489,0001.12%
Jackson Square Partners, LLC 1,778,966$204,403,0001.07%
View complete list of HAEMONETICS CORP shareholders